BioLargo, Inc. (BLGO) stock
BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
$0.07+0.00 (+0.90%)
Close on Oct 19, 2026Market cap $23.27MP/E –Yield –
BioLargo operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
BioLargo's operating cash flow for the twelve months ending Jun 30, 2026 was -$10.32M. For fiscal 2025 it was -$8.30M. The highest annual figure on record is -$1.21M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.30M | – |
| FY2024 | Dec 31, 2024 | -$3.21M | – |
| FY2023 | Dec 31, 2023 | -$2.37M | – |
| FY2022 | Dec 31, 2022 | -$2.76M | – |
| FY2021 | Dec 31, 2021 | -$3.94M | – |
| FY2020 | Dec 31, 2020 | -$4.15M | – |
| FY2019 | Dec 31, 2019 | -$4.42M | – |
| FY2018 | Dec 31, 2018 | -$3.89M | – |
| FY2017 | Dec 31, 2017 | -$4.28M | – |
| FY2016 | Dec 31, 2016 | -$3.72M | – |
| FY2015 | Dec 31, 2015 | -$1.88M | – |
| FY2014 | Dec 31, 2014 | -$1.72M | – |
| FY2013 | Dec 31, 2013 | -$1.21M | – |
| FY2012 | Dec 31, 2012 | -$2.03M | – |
| FY2011 | Dec 31, 2011 | -$1.72M | – |
| FY2010 | Dec 31, 2010 | -$1.30M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.06M | – |
| Q1 FY2026 | Mar 31, 2026 | -$2.92M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.59M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.76M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.12M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.83M | -480.5% |
| Q4 FY2024 | Dec 31, 2024 | -$1.92M | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.62M | – |
| Q2 FY2024 | Jun 30, 2024 | -$151.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $481.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.00K | -104.9% |
| Q3 FY2023 | Sep 30, 2023 | -$836.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.48M | – |
| Q1 FY2023 | Mar 31, 2023 | -$43.00K | – |
| Q4 FY2022 | Dec 31, 2022 | $41.00K | – |
| Q3 FY2022 | Sep 30, 2022 | -$939.00K | – |
| Q2 FY2022 | Jun 30, 2022 | -$724.00K | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.14M | – |
| Q4 FY2021 | Dec 31, 2021 | -$975.00K | – |
| Q3 FY2021 | Sep 30, 2021 | -$908.00K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.21M | – |
| Q1 FY2021 | Mar 31, 2021 | -$845.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$836.00K | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.27M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.29M | – |
| Q1 FY2020 | Mar 31, 2020 | -$753.00K | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.24M | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$982.00K | – |
| Q1 FY2019 | Mar 31, 2019 | -$869.00K | – |
| Q4 FY2018 | Dec 31, 2018 | -$840.00K | – |
| Q3 FY2018 | Sep 30, 2018 | -$998.00K | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.06M | – |
| Q1 FY2018 | Mar 31, 2018 | -$996.00K | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.21M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.03M | – |
| Q2 FY2017 | Jun 30, 2017 | -$872.38K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.18M | – |
| Q4 FY2016 | Dec 31, 2016 | -$921.82K | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.11M | – |
See a number that looks wrong?